Cancer Chemotherapy and Pharmacology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2– advanced breast cancer in Chinese women.
88:131-141.
2021
-
Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues.
72:127-138.
2013
-
Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours.
71:543-549.
2013
-
A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer.
68:1199-1206.
2011
-
Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model.
68:661-668.
2011
-
A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer.
67:927-933.
2011
-
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies.
66:1079-1085.
2010
-
Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.
59:621-629.
2007
-
A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy.
57:412-426.
2006
-
Clinical application of a semimechanistic-physiologic population PK/PD model for neutropenia following pemetrexed therapy.
57:427-435.
2006
-
Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment.
56:189-198.
2005
-
Inhibition by doxycycline of angiogenesis in the chicken chorioallantoic membrane (CAM).
56:1-9.
2005
-
Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells.
56:29-38.
2005
-
Carboplatin hypersensitivity presenting as coronary vasospasm - a case report.
50:429-431.
2002
-
Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer.
40:19-22.
1997
-
Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*).
38:245-253.
1996
-
Taxol encapsulation in poly(epsilon-caprolactone) microspheres.
36:279-282.
1995
-
Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts.
31:146-150.
1992
-
Evidence for lack of mitochondrial DNA repair followingcis-dichlorodiammineplatinum treatment.
26:97-100.
1990
-
Effect of whole-body hyperthermia on hepatic cytochrome P450.
25:342-344.
1990
-
A phase I?II study of combination therapy with thymidine and cytosine arabinoside.
11:43-47.
1983
-
Interaction of VP16-213 with the DNA repair antagonist chloroquine.
7:123-126.
1982
-
Podophyllotoxin derivative VP 16-213.
3:71-80.
1979
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)